IBDEI10X ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16646,1,3,0)
 ;;=3^Malig Neop Right Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,16646,1,4,0)
 ;;=4^C50.921
 ;;^UTILITY(U,$J,358.3,16646,2)
 ;;=^5001198
 ;;^UTILITY(U,$J,358.3,16647,0)
 ;;=C90.02^^61^775^176
 ;;^UTILITY(U,$J,358.3,16647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16647,1,3,0)
 ;;=3^Multiple Myeloma,In Relapse
 ;;^UTILITY(U,$J,358.3,16647,1,4,0)
 ;;=4^C90.02
 ;;^UTILITY(U,$J,358.3,16647,2)
 ;;=^5001753
 ;;^UTILITY(U,$J,358.3,16648,0)
 ;;=D51.9^^61^775^25
 ;;^UTILITY(U,$J,358.3,16648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16648,1,3,0)
 ;;=3^Anemia in Vitamin B12 Deficiency
 ;;^UTILITY(U,$J,358.3,16648,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,16648,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,16649,0)
 ;;=C79.51^^61^775^35
 ;;^UTILITY(U,$J,358.3,16649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16649,1,3,0)
 ;;=3^Bone Mets
 ;;^UTILITY(U,$J,358.3,16649,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,16649,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,16650,0)
 ;;=C80.1^^61^775^171
 ;;^UTILITY(U,$J,358.3,16650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16650,1,3,0)
 ;;=3^Malig Neop,Primary,Unspec Site
 ;;^UTILITY(U,$J,358.3,16650,1,4,0)
 ;;=4^C80.1
 ;;^UTILITY(U,$J,358.3,16650,2)
 ;;=^5001389
 ;;^UTILITY(U,$J,358.3,16651,0)
 ;;=C80.0^^61^775^172
 ;;^UTILITY(U,$J,358.3,16651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16651,1,3,0)
 ;;=3^Malig Neop,Unspec Primary or Secondary
 ;;^UTILITY(U,$J,358.3,16651,1,4,0)
 ;;=4^C80.0
 ;;^UTILITY(U,$J,358.3,16651,2)
 ;;=^5001388
 ;;^UTILITY(U,$J,358.3,16652,0)
 ;;=E28.39^^61^775^96
 ;;^UTILITY(U,$J,358.3,16652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16652,1,3,0)
 ;;=3^Hypogonadism,Ovarian
 ;;^UTILITY(U,$J,358.3,16652,1,4,0)
 ;;=4^E28.39
 ;;^UTILITY(U,$J,358.3,16652,2)
 ;;=^5002752
 ;;^UTILITY(U,$J,358.3,16653,0)
 ;;=E29.1^^61^775^97
 ;;^UTILITY(U,$J,358.3,16653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16653,1,3,0)
 ;;=3^Hypogonadism,Testicular
 ;;^UTILITY(U,$J,358.3,16653,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,16653,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,16654,0)
 ;;=C96.20^^61^775^111
 ;;^UTILITY(U,$J,358.3,16654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16654,1,3,0)
 ;;=3^Malig Mast Cell Neoplasm,Unspec
 ;;^UTILITY(U,$J,358.3,16654,1,4,0)
 ;;=4^C96.20
 ;;^UTILITY(U,$J,358.3,16654,2)
 ;;=^5151293
 ;;^UTILITY(U,$J,358.3,16655,0)
 ;;=C96.22^^61^775^173
 ;;^UTILITY(U,$J,358.3,16655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16655,1,3,0)
 ;;=3^Mast Cell Sarcoma
 ;;^UTILITY(U,$J,358.3,16655,1,4,0)
 ;;=4^C96.22
 ;;^UTILITY(U,$J,358.3,16655,2)
 ;;=^5151295
 ;;^UTILITY(U,$J,358.3,16656,0)
 ;;=D64.9^^61^775^26
 ;;^UTILITY(U,$J,358.3,16656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16656,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,16656,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,16656,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,16657,0)
 ;;=D59.10^^61^775^32
 ;;^UTILITY(U,$J,358.3,16657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16657,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,16657,1,4,0)
 ;;=4^D59.10
 ;;^UTILITY(U,$J,358.3,16657,2)
 ;;=^5159101
 ;;^UTILITY(U,$J,358.3,16658,0)
 ;;=D59.11^^61^775^33
 ;;^UTILITY(U,$J,358.3,16658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16658,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Warm
 ;;^UTILITY(U,$J,358.3,16658,1,4,0)
 ;;=4^D59.11
